CIK 0001514183 · Non-accelerated filer<br>Smaller reporting company
Silo Pharma, Inc.
Sign in to watch- Ticker
- SILO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462137136
- Phone
- (718) 400-9031
- Business address
- 677 N. WASHINGTON BLVD, SARASOTA, FL, 34236
- Former names
- Uppercut Brands, Inc., Point Capital, Inc., Gold Swap Inc
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $0.37 ($735)
- 4 Open-market buy Chief Executive Officer bought 12,000 shares at an average $0.40 ($4,847)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-1 Offering Registration Statement
- 8-K Event Executive or director change · Shareholder vote results
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Unregistered share sale · Other events
- 424B5 Offering Prospectus
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K Event Material agreement
Page 3 of 19 · 380 filings